SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cnova N.V. (CNVAF) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分: 14/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CNVAF
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.04
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.27
每股账面价值$0.00
每股营收$2.98
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2015 |
$-0.59 |
$3.42B |
$-261.7M |
-7.7% |
| 2016 |
$0.20 |
$1.86B |
$73.09M |
3.9% |
| 2017 |
$-0.29 |
$2.12B |
$-100.03M |
-4.7% |
| 2018 |
$-0.09 |
$2.17B |
$-30.79M |
-1.4% |
| 2019 |
$-0.19 |
$2.19B |
$-65.43M |
-3% |
| 2020 |
$-0.05 |
$2.22B |
$-15.67M |
-0.7% |
| 2021 |
$-0.13 |
$2.17B |
$-45.99M |
-2.1% |
| 2022 |
$-0.37 |
$1.7B |
$-128.03M |
-7.5% |
| 2023 |
$-0.73 |
$1.2B |
$-125.6M |
-10.5% |
| 2024 |
$-0.27 |
$1.04B |
$-94.19M |
-9.1% |